hVIVO’s CEO introduces their new state-of-the-art facility at Canary Wharf
hVIVO plc (formerly Open Orphan plc), led by Cathal Friel, is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and